Amarantus Bioscience Holdings Inc (AMBS)

[Solantey]

Back on the AMBS Bus

After considerable thought and after reviewing yesterday's presentation and the recent news it is obvious that there is a lot going on behind the scenes that will reap dividends this year.

I was impressed that the company was able to license the Alzheimer's blood test developed at Georgetown University..

I do expect that the company will spin off the diagnostics division this year and I think that alone justifies the current share price.

p.s. Less than a penny downside and .15-.20 upside this year.